IN2014DN07762A - - Google Patents
Info
- Publication number
- IN2014DN07762A IN2014DN07762A IN7762DEN2014A IN2014DN07762A IN 2014DN07762 A IN2014DN07762 A IN 2014DN07762A IN 7762DEN2014 A IN7762DEN2014 A IN 7762DEN2014A IN 2014DN07762 A IN2014DN07762 A IN 2014DN07762A
- Authority
- IN
- India
- Prior art keywords
- solifenacin
- reacting
- salt
- prepare
- organic solvent
- Prior art date
Links
- FBOUYBDGKBSUES-VXKWHMMOSA-N solifenacin Chemical compound C1([C@H]2C3=CC=CC=C3CCN2C(O[C@@H]2C3CCN(CC3)C2)=O)=CC=CC=C1 FBOUYBDGKBSUES-VXKWHMMOSA-N 0.000 abstract 5
- 229960003855 solifenacin Drugs 0.000 abstract 5
- IOVVFSGCNWQFQT-UHFFFAOYSA-N bis(2,3,4,5,6-pentafluorophenyl) carbonate Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1OC(=O)OC1=C(F)C(F)=C(F)C(F)=C1F IOVVFSGCNWQFQT-UHFFFAOYSA-N 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- FSNYTEYOTCTPSO-SSDOTTSWSA-N (2r)-1-azabicyclo[2.2.2]octan-2-ol Chemical compound C1CN2[C@H](O)CC1CC2 FSNYTEYOTCTPSO-SSDOTTSWSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120031492A KR101365849B1 (ko) | 2012-03-28 | 2012-03-28 | 솔리페나신 또는 그의 염의 제조방법 및 이에 사용되는 신규 중간체 |
| PCT/KR2013/002358 WO2013147458A1 (en) | 2012-03-28 | 2013-03-21 | Process of preparing solifenacin or salt thereof, and novel intermediate used in the process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07762A true IN2014DN07762A (enExample) | 2015-05-15 |
Family
ID=49260649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7762DEN2014 IN2014DN07762A (enExample) | 2012-03-28 | 2013-03-21 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9018379B1 (enExample) |
| EP (1) | EP2831070A4 (enExample) |
| JP (1) | JP5891334B2 (enExample) |
| KR (1) | KR101365849B1 (enExample) |
| CN (1) | CN104169280A (enExample) |
| AU (1) | AU2013240842B2 (enExample) |
| BR (1) | BR112014021223A2 (enExample) |
| IN (1) | IN2014DN07762A (enExample) |
| WO (1) | WO2013147458A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116986986A (zh) * | 2023-07-19 | 2023-11-03 | 杭州国瑞生物科技有限公司 | 一种3-氧代-1-环丁烷羧酸中间体的合成方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2005012I1 (no) | 1994-12-28 | 2005-06-06 | Debio Rech Pharma Sa | Triptorelin og farmasoytisk akseptable salter derav |
| AU731387B2 (en) * | 1996-03-20 | 2001-03-29 | Scripps Research Institute, The | Azatide peptidomimetics |
| KR100669823B1 (ko) | 2001-02-20 | 2007-01-17 | 경동제약 주식회사 | 2-(4-클로로벤조일아미노)-3-[2(1ｈ)-퀴놀리논-4-일]프로피온산의 제조방법 및 그 중간체 |
| WO2004035577A2 (en) * | 2002-10-16 | 2004-04-29 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
| GB0312426D0 (en) * | 2003-05-30 | 2003-07-09 | Albachem Ltd | Purification means |
| WO2005075474A1 (ja) | 2004-02-09 | 2005-08-18 | Astellas Pharma Inc. | コハク酸ソリフェナシン含有組成物 |
| JPWO2005087231A1 (ja) | 2004-03-16 | 2008-01-24 | アステラス製薬株式会社 | ソリフェナシン含有組成物 |
| CA2562713A1 (en) * | 2004-04-14 | 2005-12-15 | Gilead Sciences, Inc. | Phosphonate analogs of hiv integrase inhibitor compounds |
| JP4803352B2 (ja) * | 2005-07-13 | 2011-10-26 | Ｊｓｒ株式会社 | アミノ酸−ｎ−カルボキシ無水物の製造方法 |
| EP1879867A2 (en) * | 2005-12-21 | 2008-01-23 | Teva Pharmaceutical Industries Ltd | Intermediates for preparing solifenacin |
| WO2008062282A2 (en) | 2006-11-22 | 2008-05-29 | Medichem S.A. | An improved process for the synthesis of solifenacin |
| WO2008120080A2 (en) | 2007-03-30 | 2008-10-09 | Medichem, S.A. | An improved process for the synthesis of solifenacin |
| JP2009538362A (ja) * | 2007-07-13 | 2009-11-05 | テバ ファーマシューティカル インダストリーズ リミティド | ソリフェナシンの調製方法 |
| MX2010011800A (es) * | 2008-04-29 | 2011-06-20 | Ascendis Pharma As | Compuestos de hormona de crecimiento humana recombinante unidos a peg. |
| ES2753979T3 (es) * | 2009-03-09 | 2020-04-15 | Megafine Pharma P Ltd | Un nuevo método para la preparación de solifenacina y nuevo intermedio de la misma |
| US8178700B2 (en) * | 2009-05-04 | 2012-05-15 | International Business Machines Corporation | Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates |
| WO2011030139A1 (en) * | 2009-09-11 | 2011-03-17 | Astrazeneca Ab | 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
-
2012
- 2012-03-28 KR KR20120031492A patent/KR101365849B1/ko active Active
-
2013
- 2013-03-21 BR BR112014021223-6A patent/BR112014021223A2/pt not_active IP Right Cessation
- 2013-03-21 IN IN7762DEN2014 patent/IN2014DN07762A/en unknown
- 2013-03-21 WO PCT/KR2013/002358 patent/WO2013147458A1/en not_active Ceased
- 2013-03-21 CN CN201380016063.XA patent/CN104169280A/zh active Pending
- 2013-03-21 AU AU2013240842A patent/AU2013240842B2/en not_active Ceased
- 2013-03-21 JP JP2015501582A patent/JP5891334B2/ja active Active
- 2013-03-21 US US14/382,529 patent/US9018379B1/en not_active Expired - Fee Related
- 2013-03-21 EP EP13768214.2A patent/EP2831070A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013240842A1 (en) | 2014-08-28 |
| AU2013240842B2 (en) | 2015-09-03 |
| EP2831070A1 (en) | 2015-02-04 |
| JP2015510927A (ja) | 2015-04-13 |
| US9018379B1 (en) | 2015-04-28 |
| KR101365849B1 (ko) | 2014-02-24 |
| JP5891334B2 (ja) | 2016-03-22 |
| US20150112072A1 (en) | 2015-04-23 |
| EP2831070A4 (en) | 2015-08-19 |
| BR112014021223A2 (pt) | 2020-10-27 |
| WO2013147458A1 (en) | 2013-10-03 |
| KR20130109609A (ko) | 2013-10-08 |
| CN104169280A (zh) | 2014-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3778606A3 (en) | Condensed imidazolylimidazoles as antiviral compounds | |
| MX2014002087A (es) | Formulaciones piretroides. | |
| MX2015003124A (es) | Formas polimorficas de enzalutamida y su preparacion. | |
| EP2484673A3 (en) | A process for the resolution of (R,S)-nicotine | |
| WO2013112212A3 (en) | Metal-organic frameworks with exceptionally large pore aperatures | |
| TN2013000347A1 (en) | Production method of optically active dihydrobenzofuran derivative | |
| IN2015KN00323A (enExample) | ||
| MX2013015119A (es) | Proceso para preparar infraestructura metal - organica porosa compuesta de metilimidazolato de zinc. | |
| DK2548949T3 (da) | Mikroorganisme med forbedret produktion af 5'-xanthosinmonophosphat og 5'-guaninmonophosphat samt fremgangsmåde til fremstilling af 5'-xanthosinmonophosphat og 5'-guaninmonophosphat under anvendelse af samme | |
| NZ727045A (en) | Camsylate salt of (1r,1’r,4r)- 4-methoxy-5’’-methyl-6’-[5-(prop-1-yn-1-yl)pyridin-3-yl]-3’h-dispiro[cyclohexane-1,2’-indene-1’,2’’-imidazol]-4’’-amine | |
| WO2012178129A3 (en) | Quaternary heteroatom containing compounds | |
| MY164371A (en) | Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase | |
| MX2015011724A (es) | Sal de sodio del acido (2s, 5r) -6-benciloxi-7-oxo-1,6-diaza-bicic lo [3.2.1] octano-2-carboxilico y proceso para su preparacion. | |
| MY170511A (en) | Colonoscopy-preparation | |
| PH12015500794A1 (en) | Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same | |
| IN2014KN02722A (enExample) | ||
| WO2014097272A3 (en) | Process for the preparation of (s,s)-6-benzloctahydro-1 h-pyrrolo[3,4-b]pyridine,an intermediate of azabicyclopyridine derivatives | |
| IN2014DN07762A (enExample) | ||
| MY165744A (en) | Process for the preparation of trisilylamine from monochlorosilane and ammonia | |
| WO2014064712A3 (en) | An improved process for the preparation of fulvestrant | |
| GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof | |
| EA201200756A1 (ru) | Лиофилизат соединения бороновой кислоты | |
| IN2014DN07407A (enExample) | ||
| IN2013MU03755A (enExample) | ||
| MY172619A (en) | Method for refining quinolinic acid |